This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ PrePrints) and either DOI or URL of the article must be cited.
The Multidisciplinary Conference on Drug Research is being organized every two years since 1999 under auspices of Pharmaceutical Research Institute and constitutes a forum for presenting research results, exchange views and multi-faceted discussion between professionals associated with the broader science of medicine. The lectures cover topics in the field of medicinal chemistry, organic synthesis and technology, pharmaceutical analysis and clinical and pharmaceutical technology. Scientific program of MKNOL (Polish acronym of the conference) reflects the intention of Scientific Committee to comprise various aspects of drug discovery development process, stressing from the beginning the need for multidisciplinary communication of all researchers interested in scientific progress for betterment of human life. Past editions of the MKNOL: a) I. Muszyna, 3-5 March 1999, b) II. Jelenia Góra-Cieplice, 5-7 April 2000, c) III. Piła, 13-16 May 2002, d) IV. Gdańsk-Sobieszewo 17-19 May 2004, e) V. Darłówko Wschodnie, 15-17 May 2006, f) VI. Przemyśl-Krasiczyn, 26-28 May 2008, g) VII. Zakopane, 10-12 May 2010, h) VIII. Ossa koło Rawy Mazowieckiej, 30 May -1 June 2012, i) IX. Korytnica koło Szydłowa, 12-14 May 2014. We hope that the X MKNOL will be also a great opportunity to share new scientific achievements.
This is an Abstract submitted to the X MKNOL Conference